Rofecoxib [Vioxx] appears to increase the risk of myocardial infarction (MI) and sudden cardiac death (SCD) compared with celecoxib

By  

Reactions Weekly, Vol. 1, Iss. 1020, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Rofecoxib, valdecoxib and celecoxib are associated with increased risks of myocardial infarction (MI) in patients with rheumatic disease

By  

Reactions Weekly, Vol. 1, Iss. 1179, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Could Influenza Vaccination Prevent Myocardial Infarction, Stroke and Sudden Cardiac Death?

By Meyers D.G.  

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 4, 2003-01 ,pp. : 241-244

Adis International

Access to resources Recommend Favorite

Does Sildenafil Cause Myocardial Infarction or Sudden Cardiac Death?

By Kontaras Konstantinos   Varnavas Varnavas   Kyriakides Zenon S.  

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 1, 2008-01 ,pp. : 1-7

Adis International

Access to resources Recommend Favorite

Celecoxib: increased risk of myocardial infarction

By  

Inpharma, Vol. 1, Iss. 1528, 2006-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite